{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:58:01Z","timestamp":1793332681366,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001081","name":"Hunter Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.matbio.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T11:01:11Z","timestamp":1676113271000},"page":"16-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-3128","authenticated-orcid":false,"given":"Yazmin","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep S.","family":"Tanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.matbio.2023.02.004_bib0001","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","article-title":"Acquired chemotherapy resistance in ovarian cancer","volume":"28","author":"Christie","year":"2017","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0002","doi-asserted-by":"crossref","first-page":"031902","DOI":"10.1063\/1.5022595","article-title":"The extracellular matrix of ovarian cortical inclusion cysts modulates invasion of fallopian tube epithelial cells","volume":"2","author":"Fleszar","year":"2018","journal-title":"APL Bioeng"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"12","key":"10.1016\/j.matbio.2023.02.004_bib0004","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-18-0203","article-title":"Chronic medical conditions and CA125 levels among women without ovarian cancermedical conditions and CA125 in women without ovarian cancer","volume":"27","author":"Akinwunmi","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.matbio.2023.02.004_bib0005","unstructured":"Crosby D., Glover L., Martyn F., Wingfield M. CA125 measured during menstruation can be misleading. 2018."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0006","first-page":"2837","article-title":"OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal","volume":"92","author":"van Haaften-Day","year":"2001","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0008","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"issue":"10214","key":"10.1016\/j.matbio.2023.02.004_bib0011","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(19)32259-7","article-title":"Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial","volume":"394","author":"Clamp","year":"2019","journal-title":"Lancet N. Am. Ed."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0013","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0014","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.matbio.2023.02.004_bib0015","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0016","doi-asserted-by":"crossref","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","article-title":"Overview of the matrisome-an inventory of extracellular matrix constituents and functions","volume":"4","author":"Hynes","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0017","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/ijms19103028","article-title":"Role of extracellular matrix in development and cancer progression","volume":"19","author":"Walker","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.matbio.2023.02.004_bib0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","article-title":"Extracellular matrix in the tumor microenvironment and its impact on cancer therapy","volume":"6","author":"Henke","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.matbio.2023.02.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-21-0536","article-title":"TGFBI production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer","author":"Lecker","year":"2021","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.matbio.2023.02.004_bib0020","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1074\/jbc.R300038200","article-title":"Integrins in mechanotransduction","volume":"279","author":"Katsumi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2023.02.004_bib0021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.addr.2015.10.007","article-title":"In vitro cancer cell\u2013ECM interactions inform in vivo cancer treatment","volume":"97","author":"Holle","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.matbio.2023.02.004_bib0022","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrm3908","article-title":"Stretching the boundaries of extracellular matrix research","volume":"15","author":"Hynes","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0023","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer","volume":"4","author":"Cox","year":"2011","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.matbio.2023.02.004_bib0024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2015.00245","article-title":"The extracellular matrix in epithelial ovarian cancer-a piece of a puzzle","volume":"5","author":"Cho","year":"2015","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0025","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0026","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.matbio.2023.02.004_bib0027","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1158\/1078-0432.CCR-17-0638","article-title":"Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses","volume":"23","author":"Hao","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0028","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41467-020-15089-z","article-title":"Why the dual origins of high grade serous ovarian cancer matter","volume":"11","author":"Colvin","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/excr.1994.1320","article-title":"Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix","volume":"215","author":"Kruk","year":"1994","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.matbio.2023.02.004_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/S401","article-title":"The origin of ovarian cancers\u2013hypotheses and controversies","volume":"5","author":"Auersperg","year":"2013","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0031","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/carcin\/bgt003","article-title":"Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction","volume":"34","author":"King","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It's Totally Tubular\u2026Riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0033","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0034","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.2016.238","article-title":"Serous tubal intraepithelial neoplasia: the concept and its application","volume":"30","author":"Meserve","year":"2017","journal-title":"Mod. Pathol."},{"issue":"17","key":"10.1016\/j.matbio.2023.02.004_bib0036","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0037","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/cancers11060884","article-title":"Loss of PTEN in fallopian tube epithelium results in multicellular tumor spheroid formation and metastasis to the ovary","volume":"11","author":"Dean","year":"2019","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.matbio.2023.02.004_bib0038","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/carcin\/bgaa068","article-title":"NF-\u03baB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium","volume":"41","author":"Brand","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.matbio.2023.02.004_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-0716-1956-8_13","article-title":"Ex vivo ovarian culture to model the initial metastasis in ovarian cancer","volume":"2424","author":"Dean","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102676","article-title":"A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasion","volume":"24","author":"Malacrida","year":"2021","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0041","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/acs.jproteome.7b00191","article-title":"Characterization of the extracellular matrix of normal and diseased tissues using proteomics","volume":"16","author":"Naba","year":"2017","journal-title":"J. Proteome Res."},{"issue":"44","key":"10.1016\/j.matbio.2023.02.004_bib0042","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208040119","article-title":"Bovine and human endometrium-derived hydrogels support organoid culture from healthy and cancerous tissues","volume":"119","author":"Jamaluddin","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0043","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.trecan.2020.10.009","article-title":"3D in vitro model (R)evolution: unveiling tumor\u2013stroma interactions","volume":"7","author":"Rodrigues","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.matbio.2023.02.004_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.836984","article-title":"Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine","volume":"10","author":"Yee","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111805","article-title":"Imaging collagen alterations in stics and high grade ovarian cancers in the fallopian tubes by second harmonic generation microscopy","volume":"11","author":"Rentchler","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JBO.24.6.066501","article-title":"Polarization-resolved second harmonic generation imaging of human ovarian cancer","volume":"23","author":"Campbell","year":"2018","journal-title":"J. Biomed. Opt."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112794","article-title":"Evaluation of collagen alterations in early precursor lesions of high grade serous ovarian cancer by second harmonic generation microscopy and mass spectrometry","volume":"13","author":"Gant","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0048","first-page":"956","article-title":"Organization of the fibrous connective tissue of the fallopian tubes in fertile and climacteric periods: a scanning electron microscopic and stereologic study","volume":"14","author":"Souza","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"28","key":"10.1016\/j.matbio.2023.02.004_bib0049","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1073\/pnas.1817442116","article-title":"Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix","volume":"116","author":"Jailkhani","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0050","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103988","article-title":"Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes","volume":"9","author":"Beaufort","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0052","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13073-021-00952-5","article-title":"Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes","volume":"13","author":"Barnes","year":"2021","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0053","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1038\/s41598-019-41941-4","article-title":"Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas","volume":"9","author":"Hallas-Potts","year":"2019","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.matbio.2023.02.004_bib0054","doi-asserted-by":"crossref","first-page":"32810","DOI":"10.18632\/oncotarget.9053","article-title":"Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease","volume":"7","author":"Haley","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"Mitra","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0056","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ygyno.2016.05.028","article-title":"Characterization of ovarian cancer cell lines as in vivo models for preclinical studies","volume":"142","author":"Hernandez","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108800","article-title":"Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK","volume":"34","author":"Masi","year":"2021","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.matbio.2023.02.004_bib0058","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/nar\/gkw578","article-title":"Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line","volume":"44","author":"Blayney","year":"2016","journal-title":"Nucleic Acids. Res."},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109412","article-title":"Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING","volume":"36","author":"Bruand","year":"2021","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051250","article-title":"A novel role for NUAK1 in promoting ovarian cancer metastasis through regulation of fibronectin production in spheroids","volume":"12","author":"Fritz","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0061","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/CNV-120000374","article-title":"Order and disorder: the role of extracellular matrix in epithelial cancer","volume":"20","author":"Radisky","year":"2002","journal-title":"Cancer Investig."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0062","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1369\/00221554211061359","article-title":"Multi-modal profiling of the extracellular matrix of human fallopian tubes and serous tubal intraepithelial carcinomas","volume":"70","author":"Renner","year":"2022","journal-title":"J. Histochem. Cytochem."},{"issue":"7","key":"10.1016\/j.matbio.2023.02.004_bib0063","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ijc.25494","article-title":"Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells","volume":"128","author":"Ween","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0064","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.3390\/ijms130810461","article-title":"Transforming growth Factor-Beta-Induced Protein (TGFBI)\/(\u03b2ig-H3): a matrix protein with dual functions in ovarian cancer","volume":"13","author":"Ween","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/IGC.0000000000000933","article-title":"Changes in the extracellular matrix are associated with the development of serous tubal intraepithelial carcinoma into high-grade serous carcinoma","volume":"27","author":"van der Steen","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0066","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.matbio.2023.02.004_bib0067","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/nprot.2007.227","article-title":"Analysis of protein glycosylation by mass spectrometry","volume":"2","author":"Morelle","year":"2007","journal-title":"Nat. Protoc."},{"issue":"24","key":"10.1016\/j.matbio.2023.02.004_bib0068","doi-asserted-by":"crossref","first-page":"15693","DOI":"10.1021\/acs.analchem.0c03104","article-title":"Photocleavable surfactant-enabled extracellular matrix proteomics","volume":"92","author":"Knott","year":"2020","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0069","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/carcin\/bgy170","article-title":"Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer","volume":"40","author":"Dean","year":"2019","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.matbio.2023.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1541-7786.MCR-19-1057","article-title":"Targeting fatty acid oxidation to promote anoikis and inhibit ovarian cancer progression","volume":"18","author":"Sawyer","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"10.1016\/j.matbio.2023.02.004_bib0071","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121957","article-title":"Ovarian cancer dissemination-a cell biologist's perspective","volume":"11","author":"Farsinejad","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0072","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s42003-022-04314-8","article-title":"L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary","volume":"5","author":"Doberstein","year":"2022","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0073","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86829","article-title":"Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition","volume":"1","author":"Iwanicki","year":"2016","journal-title":"JCI Insight"},{"issue":"7353","key":"10.1016\/j.matbio.2023.02.004_bib0074","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.matbio.2023.02.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215779","article-title":"Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer","volume":"543","author":"Russo","year":"2022","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.matbio.2023.02.004_bib0076","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41388-017-0097-8","article-title":"PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation","volume":"37","author":"Russo","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0077","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12935-019-1022-8","article-title":"PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin \u03b23","volume":"19","author":"Soriano","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0078","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PGP.0000000000000120","article-title":"Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis","volume":"34","author":"Banet","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0079","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/intbio\/zyz028","article-title":"Substrate curvature induces fallopian tube epithelial cell invasion via cell\u2013cell tension in a model of ovarian cortical inclusion cysts","volume":"11","author":"Fleszar","year":"2019","journal-title":"Integr. Biol."},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/rep.0.1260415","article-title":"Extracellular matrix of the developing ovarian follicle","volume":"126","author":"Rodgers","year":"2003","journal-title":"Reproduction"},{"issue":"8 Suppl","key":"10.1016\/j.matbio.2023.02.004_bib0081","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719107309818","article-title":"The role of the extracellular matrix in ovarian follicle development","volume":"14","author":"Woodruff","year":"2007","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0082","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.matbio.2023.02.004_bib0083","first-page":"184","article-title":"Three-dimensional modeling of ovarian cancer","volume":"0","author":"Erin","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0084","doi-asserted-by":"crossref","first-page":"T155","DOI":"10.1530\/ERC-16-0320","article-title":"Ovarian cancer-peritoneal cell interactions promote extracellular matrix processing","volume":"23","author":"Ricciardelli","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0085","first-page":"150","article-title":"Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells","volume":"16","author":"Fishman","year":"1996","journal-title":"Invasion Metastasis"},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0086","doi-asserted-by":"crossref","DOI":"10.1063\/5.0047523","article-title":"Topological defects in the mesothelium suppress ovarian cancer cell clearance","volume":"5","author":"Zhang","year":"2021","journal-title":"APL Bioeng."},{"key":"10.1016\/j.matbio.2023.02.004_bib0087","article-title":"In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis","volume":"60","author":"Davidowitz","year":"2012","journal-title":"J. Vis. Exp. JoVE"},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0088","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0089","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-18-2616","article-title":"Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis","volume":"79","author":"Natarajan","year":"2019","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.matbio.2023.02.004_bib0090","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1158\/0008-5472.CAN-19-3717","article-title":"Peritoneal spread of ovarian cancer harbors therapeutic vulnerabilities regulated by FOXM1 and EGFR\/ERBB2 signaling","volume":"80","author":"Parashar","year":"2020","journal-title":"Cancer Res."},{"issue":"37","key":"10.1016\/j.matbio.2023.02.004_bib0091","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.matbio.2023.02.004_bib0092","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","article-title":"Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination","volume":"69","author":"Moss","year":"2009","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0093","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081187","article-title":"4-methylumbelliferone inhibits cancer stem cell activation and overcomes chemoresistance in ovarian cancer","volume":"11","author":"Lokman","year":"2019","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.matbio.2023.02.004_bib0095","doi-asserted-by":"crossref","first-page":"25930","DOI":"10.18632\/oncotarget.8412","article-title":"miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0096","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000942","article-title":"Extracellular matrix mediates moruloid-blastuloid morphodynamics in malignant ovarian spheroids","volume":"4","author":"Langthasa","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0097","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ijc.2910520115","article-title":"Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines","volume":"52","author":"M\u00f6bus","year":"1992","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0098","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1878-0261.12845","article-title":"Constitutive activation of integrin \u03b1v\u03b23 contributes to anoikis resistance of ovarian cancer cells","volume":"15","author":"Dolinschek","year":"2021","journal-title":"Mol. Oncol."},{"issue":"13-14","key":"10.1016\/j.matbio.2023.02.004_bib0099","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/ten.tea.2020.0001","article-title":"Ovarian cells have increased proliferation in response to heparin-binding epidermal growth factor as collagen density increases","volume":"26","author":"Fogg","year":"2020","journal-title":"Tissue Eng. Part A"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1158\/0008-5472.CAN-21-1012","article-title":"T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy","volume":"82","author":"Haj-Shomaly","year":"2022","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0101","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0102","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13402-019-00486-4","article-title":"The exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration","volume":"43","author":"Li","year":"2020","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0103","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/23.2.237","article-title":"Overexpression of \u03b1v\u03b26 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade","volume":"23","author":"Ahmed","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.matbio.2023.02.004_bib0104","doi-asserted-by":"crossref","first-page":"e59442","DOI":"10.7554\/eLife.59442","article-title":"Collagen-rich omentum is a premetastatic niche for integrin \u03b12-mediated peritoneal metastasis","volume":"9","author":"Huang","year":"2020","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0105","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41598-021-85356-6","article-title":"Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells","volume":"11","author":"Azimian-Zavareh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.matbio.2023.02.004_bib0106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","article-title":"PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination","volume":"442","author":"Peng","year":"2019","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0107","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0108","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1878-0261.12749","article-title":"Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion","volume":"14","author":"Ojasalu","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0109","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1038\/ncomms14470","article-title":"Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer","volume":"8","author":"Yokoi","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0111","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/ijms20061466","article-title":"Therapeutic targeting of collective invasion in ovarian cancer","volume":"20","author":"Moffitt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.matbio.2023.02.004_bib0112","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and \u03b1(5)\u03b2(1)-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Mitra","year":"2011","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2010.12.362","article-title":"A phase II, single-arm study of the anti-\u03b15\u03b21 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer","volume":"121","author":"Bell-McGuinn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.matbio.2023.02.004_bib0114","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2019.05.029","article-title":"Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2\/STAT3 pathway","volume":"458","author":"Fogg","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.matbio.2023.02.004_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.matbio.2018.10.005","article-title":"Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer","volume":"81","author":"Chellini","year":"2019","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0116","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tcb.2017.03.003","article-title":"Tumor cell invadopodia: invasive protrusions that orchestrate metastasis","volume":"27","author":"Eddy","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"15","key":"10.1016\/j.matbio.2023.02.004_bib0117","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1073\/pnas.94.15.7959","article-title":"Transmembrane\/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell\u2009invasion","volume":"94","author":"Nakahara","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0118","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1158\/0008-5472.CAN-06-3928","article-title":"Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.matbio.2023.02.004_bib0119","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-\u03b2 modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.matbio.2023.02.004_bib0120","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/onc.2011.429","article-title":"Tissue transglutaminase links TGF-\u03b2, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer","volume":"31","author":"Cao","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0121","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1593\/neo.121878","article-title":"Extracellular tissue transglutaminase activates noncanonical NF-\u03baB signaling and promotes metastasis in ovarian cancer","volume":"15","author":"Yakubov","year":"2013","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0122","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/cancers11050668","article-title":"Review: targeting the transforming growth factor-beta pathway in ovarian cancer","volume":"11","author":"Roane","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.matbio.2023.02.004_bib0123","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fcell.2020.00605","article-title":"On-target anti-TGF-\u03b2 therapies are not succeeding in clinical cancer treatments: what are remaining challenges?","volume":"8","author":"Teixeira","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0124","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101513","article-title":"Transcriptome profiling reveals matrisome alteration as a key feature of ovarian cancer progression","volume":"11","author":"Mitra","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A collagen-remodeling gene signature regulated by TGF-\u03b2 signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.matbio.2023.02.004_bib0126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009228","article-title":"Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts","volume":"17","author":"Zhu","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"10.1016\/j.matbio.2023.02.004_bib0127","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","article-title":"Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers","volume":"8","author":"Pearce","year":"2018","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102674","article-title":"Modelling TGF\u03b2R and Hh pathway regulation of prognostic matrisome molecules in ovarian cancer","volume":"24","author":"Delaine-Smith","year":"2021","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0129","doi-asserted-by":"crossref","first-page":"0","DOI":"10.3802\/jgo.2021.32.e95","article-title":"Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020","volume":"32","author":"Obermair","year":"2021","journal-title":"J. Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.trecan.2016.12.005","article-title":"Tumor\u2013host cell interactions in ovarian cancer: pathways to therapy failure","volume":"3","author":"Pogge von Strandmann","year":"2017","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0132","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3892\/or.2014.3468","article-title":"Microarray-based detection and expression analysis of extracellular matrix proteins in drug\u2011resistant ovarian cancer cell lines","volume":"32","author":"Januchowski","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0133","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41467-021-24009-8","article-title":"Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance","volume":"12","author":"Pietil\u00e4","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.matbio.2023.02.004_bib0134","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761960","article-title":"High serpin family a member 10 expression confers platinum sensitivity and is associated with survival benefit in high-grade serous ovarian cancer: based on quantitative proteomic analysis","volume":"11","author":"Guo","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2407-13-476","article-title":"Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer","volume":"13","author":"Ricciardelli","year":"2013","journal-title":"BMC Cancer"},{"issue":"25","key":"10.1016\/j.matbio.2023.02.004_bib0136","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells","volume":"283","author":"Bourguignon","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0137","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1038\/s41467-021-24315-1","article-title":"Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.matbio.2023.02.004_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101742","article-title":"Engineering the extracellular matrix to model the evolving tumor microenvironment","volume":"23","author":"Micek","year":"2020","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0139","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41419-020-2442-z","article-title":"Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer","volume":"11","author":"Nallanthighal","year":"2020","journal-title":"Cell Death Dis."},{"issue":"35","key":"10.1016\/j.matbio.2023.02.004_bib0140","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/s41388-018-0297-x","article-title":"Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer","volume":"37","author":"Rada","year":"2018","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.matbio.2023.02.004_bib0141","doi-asserted-by":"crossref","first-page":"23748","DOI":"10.18632\/oncotarget.4250","article-title":"COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt\/c\/EBP\u03b2 pathway and PDK1 stabilization","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.matbio.2023.02.004_bib0142","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146186","article-title":"Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling","volume":"131","author":"Qian","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0143","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/ijc.32854","article-title":"Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1\/Akt signaling pathway","volume":"146","author":"Yoshihara","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0144","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.18632\/aging.102954","article-title":"Overexpressed ITGA2 contributes to paclitaxel resistance by ovarian cancer cells through the activation of the AKT\/FoxO1 pathway","volume":"12","author":"Ma","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.matbio.2023.02.004_bib0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejpb.2016.12.010","article-title":"Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes","volume":"113","author":"van der Steen","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.matbio.2023.02.004_bib0146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.01.029","article-title":"Chemotherapeutic drug delivery by tumoral extracellular matrix targeting","volume":"274","author":"Raav\u00e9","year":"2018","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.matbio.2023.02.004_bib0147","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0148","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.matbio.2023.02.004_bib0149","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.molmed.2021.07.009","article-title":"Extracellular matrix-based cancer targeting","volume":"27","author":"Karamanos","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"3-4","key":"10.1016\/j.matbio.2023.02.004_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1615\/CritRevOncog.2014011455","article-title":"Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics","volume":"19","author":"Engelberth","year":"2014","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.matbio.2023.02.004_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119986","article-title":"Nanoparticles in precision medicine for ovarian cancer: from chemotherapy to immunotherapy","volume":"591","author":"Li","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0152","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2012.10.008","article-title":"Lyophilisomes as a new generation of drug delivery capsules","volume":"439","author":"van Bracht","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0153","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1038\/srep18205","article-title":"A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41584-019-0350-3","article-title":"Targeting inflammation with collagen-binding antibodies","volume":"16","author":"Onuora","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0155","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1038\/s41598-021-83685-0","article-title":"Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer","volume":"11","author":"Mieulet","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0156","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"16","key":"10.1016\/j.matbio.2023.02.004_bib0157","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93076","article-title":"Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens","volume":"2","author":"Nagaraja","year":"2017","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0158","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.24188","article-title":"Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype","volume":"124","author":"Sodek","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0159","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1539613","article-title":"Blockade of TGF-\u03b2 signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models","volume":"8","author":"Newsted","year":"2019","journal-title":"Oncoimmunology"},{"issue":"36","key":"10.1016\/j.matbio.2023.02.004_bib0160","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/s41388-018-0320-2","article-title":"LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy","volume":"37","author":"Rossow","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0161","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ccr.2007.11.014","article-title":"The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel","volume":"12","author":"Ahmed","year":"2007","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.matbio.2023.02.004_bib0162","first-page":"2143","article-title":"FBLN5 is targeted by microRNA\u201127a\u20113p and suppresses tumorigenesis and progression in high\u2011grade serous ovarian carcinoma","volume":"44","author":"Li","year":"2020","journal-title":"Oncol. Rep."},{"issue":"18","key":"10.1016\/j.matbio.2023.02.004_bib0163","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.18632\/oncotarget.24484","article-title":"Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer","volume":"9","author":"Manders","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0164","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40659-020-00277-4","article-title":"Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene","volume":"53","author":"Li","year":"2020","journal-title":"Biol. Res."},{"key":"10.1016\/j.matbio.2023.02.004_bib0165","doi-asserted-by":"crossref","first-page":"602670","DOI":"10.3389\/fonc.2020.602670","article-title":"MicroRNA-18a-5p suppresses tumor growth via targeting matrix metalloproteinase-3 in cisplatin-resistant ovarian cancer","volume":"10","author":"Qui\u00f1ones-D\u00edaz","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.matbio.2023.02.004_bib0166","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: a literature review","volume":"233","author":"Hosseinahli","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.matbio.2023.02.004_bib0167","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"issue":"21","key":"10.1016\/j.matbio.2023.02.004_bib0168","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/1078-0432.CCR-19-0187","article-title":"Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer","volume":"25","author":"Yeung","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.matbio.2023.02.004_bib0169","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Shaw","year":"2004","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.matbio.2023.02.004_bib0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/annrheumdis-2011-200298","article-title":"Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study","volume":"71","author":"Boumans","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.matbio.2023.02.004_bib0171","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2018.02.006","article-title":"Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics","volume":"421","author":"Ricciardelli","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.matbio.2023.02.004_bib0172","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.710061","article-title":"Targeting the tumor extracellular matrix by the natural molecule 4-methylumbelliferone: a complementary and alternative cancer therapeutic strategy","volume":"11","author":"Vitale","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.matbio.2023.02.004_bib0173","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1038\/oncsis.2016.86","article-title":"Inhibition of the integrin\/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy","volume":"6","author":"Xu","year":"2017","journal-title":"Oncogenesis"}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X23000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X23000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:04:36Z","timestamp":1760555076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X23000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":173,"alternative-id":["S0945053X23000148"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2023.02.004","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}